References
- Moellering RC Jr. Enterococcus species, Streptococcus bovis, and Leuconostoc species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and practice of infectious diseases, 4th edn. New York: Churchill Livingstone; 2000. pp. 2147–56.
- Fuchs PC, Barry AL, Brown SD. Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centers by three methods. J Antimicrob Chemother 1999; 43: 137–40.
- Shrestha NK, Amud DA, Riebel JW, Goldman MP, Tomford JW. Treatment of a complicated vancomycin-resistant enterococcal urinary tract infection with fosfomycin. Infect Dis Clin Pract 2000; 9: 368–71.
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Tenth International Supplement. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000. M100–10.
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: Twelfth International Supplement. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002. M100–12.
- Perri MB, Hershberger E, Ionescu M, Lauter C, Zervos MJ. In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin. Diagn Microbiol Infect Dis 2002; 42: 269–71.
- Allerberger F, Klare I. In-vitro susceptibility of fosfomycin against vancomycin-resistant enterococci. J Antimicrob Chemother 1999; 43: 211–7.
- Andrews JM, Baquero F, Beltran JM, Canton E, Crokaert F, Gobernado M, et al. International collaborative study on standardization of bacterial sensitivity to fosfomycin. J Antimicrob Chemother 1983; 12: 357–61.
- Clemett D, Markham A. Linezolid. Drugs 2000; 59: 815–27, Discussion 828.
- Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000; 342: 710–21.
- Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program 1997–1999. Clin Infect Dis 2001; 32 (Suppl 2): S133–45.
- Gonzales RD, Schreckenberger PC, Graham MB, Kelkar S, DenBesten K, Quinn JP. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 2001; 357: 1179.
- 2002 Drug topics red book. Montvale, NJ: Thomson Medical Economics; 2002. pp. 441, 551, 600.
- Shrestha NK, Tomford JW. Fosfomycin: a review. Infect Dis Clin Pract 2001; 10: 255–60.